Needles to Spheres: Evaluation of inkjet printing as a particle shape enhancement tool.
Acicular drugs
Inkjet printing
Particle Engineering
Particle morphology
Personalized manufacturing
Journal
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
07
12
2022
revised:
20
01
2023
accepted:
21
01
2023
pubmed:
28
1
2023
medline:
3
3
2023
entrez:
27
1
2023
Statut:
ppublish
Résumé
Active pharmaceutical ingredients (APIs) often reveal shapes challenging to process, e.g. acicular structures, and exhibit reduced bioavailability induced by slow dissolution rate. Leveraging the API particles' surface and bulk properties offers an attractive pathway to circumvent these challenges. Inkjet printing is an attractive processing technique able to tackle these limitations already in initial stages when little material is available, while particle properties are maintained over the entire production scale. Additionally, it is applicable to a wide range of formulations and offers the possibility of co-processing with a variety of excipients to improve the API's bioavailability. This study addresses the optimization of particle shapes for processability enhancement and demonstrates the successful application of inkjet printing to engineer spherical lacosamide particles, which are usually highly acicular. By optimizing the ink formulation, adapting the substrate-liquid interface and tailoring the heat transfer to the particle, spherical particles in the vicinity of 100 µm, with improved flow properties compared to the bulk material, were produced. Furthermore, the particle size was tailored reproducibly by adjusting the deposited ink volume per cycle and the number of printing cycles. Therefore, the present study shows a novel, reliable, scalable and economical strategy to overcome challenging particle morphologies by co-processing an API with suitable excipients.
Identifiants
pubmed: 36707008
pii: S0939-6411(23)00016-4
doi: 10.1016/j.ejpb.2023.01.016
pii:
doi:
Substances chimiques
Excipients
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
92-102Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.